Primary Record
Methysergide maleate
- In stock
- 9,736 g
- Purity
- 99.6 %
- CAS
- 129-49-7
Compound Identifiers & Properties
- CAS
- 129-49-7
- PubChem CID
- 5281073
- SMILES
- CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=C\C(=O)O)\C(=O)O
- Canonical SMILES
- CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O
Names & Synonyms
- Methysergide maleate
- Sansert
- Deseril
- Deseril-retard
- methysergide
- Desernil bismaleate
- Methysergide dimaleate
- Methysergide hydrogen maleate
- Methysergide bimaleate
- Methysergide maleate salt
- 129-49-7
- Sansert (TN)
- RefChem:55624
- METHYSERGIDEMALEATE
- Methysergide maleate (USP)
- Methysergide maleate [USP]
- regid855989
- Methysergide maleate [USAN]
- 129-49-7 (maleate)
- UNII-2U7H1466GH
- 2U7H1466GH
- C25H31N3O6
- MLS000069364
- MLS001076153
- NSC-759143
- EINECS 204-950-9
- LWYXFDXUMVEZKS-ZVFOLQIPSA-N
- CHEBI:6894
- DTXSID901017106
- orb1705064
- CHEMBL1200938
- Methysergide maleate salt, solid
- NSC 186061
- SCHEMBL21803661
- DTXCID701475299
- HMS2093N13
- HMS2231L15
- HMS3262N07
- HMS3414J11
- HMS3678J09
- HMS3887O05
- Pharmakon1600-01505492
- Methysergide maleate Assay Standard
- C21H28N3O2.C4H3O4
- METHYSERGIDE MALEATE [VANDF]
- Tox21_500863
- METHYSERGIDE MALEATE [MART.]
- MFCD00083185
- NSC759143
- C21H27N3O2.2C4H4O4
- METHYSERGIDE MALEATE [USP-RS]
- METHYSERGIDE MALEATE [WHO-DD]
- AKOS024456362
- CCG-213467
- CID5281073
- FM75152
- LP00863
- 1-Methyl-D-lysergic acid butanolamide dimaleate
- NCGC00261548-01
- AN-23038
- AS-89755
- LS-64362
- METHYSERGIDE HYDROGEN MALEATE [MI]
- METHYSERGIDE MALEATE [ORANGE BOOK]
- SMR000058483
- SMR000653472
- METHYSERGIDE MALEATE [USP IMPURITY]
- 1-Methyl-D-lysergic acid butanolamide bimaleate
- METHYSERGIDE MALEATE [USP MONOGRAPH]
- B5046
- C21-H27-N3-O2.C4-H4-O4
- EU-0100863
- M-137
- NS00079311
- D00681
- G77906
- Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, maleate
- A983761
- SR-01000002986
- (+)-N-((1-Hydroxymethyl)propyl)-1-methyl-D-lysergamide bimaleate
- Ergoline-8-carboxamide,9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8b)-,(2Z)-2-butenedioate (1:1) (salt)
- SR-01000002986-2
- Q27255601
- 1-(Hydroxymethyl)propylamide of 1-methyl-(+)-lysergic acid hydrogen maleate
- 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide maleate (1:1) (salt)
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide; maleate (1:1)
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid
- Ergoline-8-beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, maleate (1:1) (salt)
- Ergoline-8-carboxamide, 9,10-didehydro-N-((1S)-1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (2Z)-2-butenedioate (1:1) (salt)
- Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (Z)-2-butenedioate (1:1) (salt)
- Ergoline-8beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, maleate (1:2) (salt)
- Methysergide maleate, United States Pharmacopeia (USP) Reference Standard
- (2Z)-But-2-enedioic acid--N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8beta-carboxamide (1/1)
- (6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;maleic acid
- (8beta)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-ergoline-8-carboxamide (2Z)-2-Butenedioate
- [8?(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide maleate
- 204-950-9
- 361-37-5
- 9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8beta-carboxamide maleate (1:1) (salt)
- Ergoline-8-beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-,maleate (1:1) (salt)
- ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N-(1-(HYDROXYMETHYL)PROPYL)-1,6-DIMETHYL-, (8.BETA.)-, (Z)-2-BUTENEDIOATE (1:1) (SALT)
- Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1- (hydroxymethyl)propyl]-1,6-dimethyl-, (8ss)-, (2Z)-2-butenedioate (1:1) (salt)
- Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8ss)-, (2Z)-2-butenedioate (1:1); Methysergide Maleate; Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8ss)-, (2Z)-2-butenedioate (1:1) (salt) (9CI); Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, [8ss(S)]-, (Z)-2-butenedioate (1:1) (salt); Ergoline-8ss-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, maleate (1:1) (salt) (8CI); Lysergamide, N-[1-(hydroxymethyl)propyl]-1-methyl-, maleate (7CI); (+)-N-[(1-Hydroxymethyl)propyl]-1-methyl-D-lysergamide bimaleate; 1-Methyl-D-lysergic acid butanolamide bimaleate; Deseril-retard; Desernil; Desernil bimaleate; Methysergide bimaleate; Methysergide hydrogen maleate; Methysergide maleate; NSC 186061; Sansert
- Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8.beta.)-, (Z)-2-butenedioate (1:2) (salt)
- Ergoline-8.beta.-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, maleate (1:2) (salt)